TipRanks
Go Ultimate55% OFF

NGeneBio Co., Ltd. (354200) Price & Analysis

354200 Stock Chart & Stats

$695.00$53.00(8.26%)
At close: 4:00 PM EDT
$1,000$1,500$2,0003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$635.00 - $834.00
52-Week Range
$633.00 - $6,979.97
Previous Close
$642.00
Volume
N/A
Average Volume (3M)
1.59M
Market Cap
KRW 11.18B
Enterprise Value
KRW 50.20B
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
N/A
Price to Earnings (P/E)
―
Beta
-0.07
Next Earnings
Nov 12, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

354200 FAQ

What was NGeneBio Co., Ltd.’s price range in the past 12 months?
NGeneBio Co., Ltd. lowest stock price was $633.00 and its highest was $6979.97 in the past 12 months.
What is NGeneBio Co., Ltd.’s market cap?
NGeneBio Co., Ltd.’s market cap is ₩11.18B.
When is NGeneBio Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NGeneBio Co., Ltd.’s earnings last quarter?
NGeneBio Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -$315.59 earnings per share for the quarter.
Is NGeneBio Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does NGeneBio Co., Ltd. pay dividends?
NGeneBio Co., Ltd. does not currently pay dividends.
What is NGeneBio Co., Ltd.’s EPS estimate?
NGeneBio Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NGeneBio Co., Ltd. have?
NGeneBio Co., Ltd. has 16,086,582 shares outstanding.
What happened to NGeneBio Co., Ltd.’s price movement after its last earnings report?
NGeneBio Co., Ltd. reported an EPS of -$315.59 in its last earnings report. Following the earnings report the stock price went down -2.059%.
Which hedge fund is a major shareholder of NGeneBio Co., Ltd.?
Currently, no hedge funds are holding shares in KR:354200
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology